WuXi AppTec(02359)
Search documents
恒生医疗低开高走,逆势收涨,截至收盘上涨0.45%。其中药明康德上涨1.68%,中国生物上涨0.78%,药明生物上涨0.43%。


Ge Long Hui· 2026-02-07 21:29
开盘后直线跳水,一条直线直接打到-2.2%,随后触底反弹,截至收盘恒生指数下跌1.21%。互联网跌幅 居前,大消费、科技等紧随其后,恒生医疗逆势红盘。 恒生互联网大幅低开后冲高回落,盘中一度大跌2.17%,截至收盘下跌1.19%。阿里巴巴下跌2.88%美团 下跌2.56%,快手下跌2.4%,地平线机器人、网易、百度等股跌幅均在2%上方。 大消费低开高走但整体弱势,截至收盘下跌0.93%。名创优品下跌4.42%,京东健康、老铺黄金、百济 神州、康师傅控股等跌幅均在2%上方;零跑汽车逆势上涨5.84%,理想汽车、蒙牛乳业等股涨幅均在 3%上方。 恒生医疗低开高走,逆势收涨,截至收盘上涨0.45%。其中药明康德上涨1.68%,中国生物上涨0.78%, 药明生物上涨0.43%。 内容只是个人观点,仅供参考,不作为投资依据!欢迎关注交流,互相学习、共同探讨! ...
药明康德:Chemistry 42属于另一家生物科技公司,和药明康德无关
Ge Long Hui· 2026-02-06 15:33
格隆汇2月6日丨药明康德(603259.SH)在投资者互动平台表示,Chemistry 42属于另一家生物科技公司, 和药明康德无关。公司历来不自行开发新药,也没有用AI来开发新药。 ...
药明康德(603259.SH):Chemistry 42属于另一家生物科技公司,和药明康德无关
Ge Long Hui· 2026-02-06 15:26
格隆汇2月6日丨药明康德(603259.SH)在投资者互动平台表示,Chemistry 42属于另一家生物科技公司, 和药明康德无关。公司历来不自行开发新药,也没有用AI来开发新药。 ...
摩根大通减持药明康德约79.81万股 每股作价约109.15港元
智通财经网· 2026-02-06 14:06
Core Viewpoint - Morgan Stanley has reduced its stake in WuXi AppTec (02359) by 798,119 shares at a price of HKD 109.1481 per share, totaling approximately HKD 87.1132 million, resulting in a new holding of about 35.2451 million shares, representing 6.90% of the company [1] Summary by Category - **Share Reduction** - Morgan Stanley sold 798,119 shares of WuXi AppTec [1] - The sale price was HKD 109.1481 per share [1] - The total amount from the sale was approximately HKD 87.1132 million [1] - **Current Holdings** - After the reduction, Morgan Stanley's remaining shares in WuXi AppTec are approximately 35.2451 million [1] - The new ownership percentage is 6.90% [1]
摩根大通减持药明康德(02359)约79.81万股 每股作价约109.15港元



智通财经网· 2026-02-06 13:30
Core Viewpoint - Morgan Stanley has reduced its stake in WuXi AppTec (02359) by selling 798,119 shares at a price of HKD 109.1481 per share, totaling approximately HKD 87.1132 million, resulting in a new holding of about 35.2451 million shares, representing 6.90% of the company [1] Group 1 - Morgan Stanley sold 798,119 shares of WuXi AppTec on February 3 [1] - The selling price per share was HKD 109.1481, leading to a total transaction value of approximately HKD 87.1132 million [1] - After the sale, Morgan Stanley's remaining shares in WuXi AppTec are approximately 35.2451 million, which constitutes a 6.90% ownership stake [1]
药明康德:2025年前三季度公司来自欧洲客户收入为38.4亿元
Zheng Quan Ri Bao Wang· 2026-02-06 13:16
证券日报网讯 2月6日,药明康德(603259)在互动平台回答投资者提问时表示,2025年前三季度,公 司来自欧洲客户收入为38.4亿元,占公司持续经营业务收入的12%。 ...
药明康德:公司历来不自行开发新药,也没有用AI来开发新药
Zheng Quan Ri Bao· 2026-02-06 13:10
(文章来源:证券日报) 证券日报网讯 2月6日,药明康德在互动平台回答投资者提问时表示,公司历来不自行开发新药,也没 有用AI来开发新药。 ...
智通港股空仓持单统计|2月6日
智通财经网· 2026-02-06 10:32
Group 1 - The top three companies with the highest short positions are COSCO Shipping Holdings (01919), Dongfang Electric (01072), and Vanke Enterprises (02202), with short ratios of 18.70%, 16.91%, and 16.66% respectively [1][2] - The companies with the largest increase in short positions are Ganfeng Lithium (01772), Sanhua Intelligent Control (02050), and CATL (03750), with increases of 2.04%, 1.63%, and 1.51% respectively [1][2] - The companies with the largest decrease in short positions are Kanglong Chemical (03759), Aneng Logistics (09956), and Changfei Optical Fiber (06869), with decreases of -1.71%, -1.68%, and -1.01% respectively [1][3] Group 2 - The latest short position data shows that COSCO Shipping Holdings has 516 million shares short, up from 511 million shares previously, while Dongfang Electric has 68.99 million shares short, down from 70.83 million shares [2] - The companies with the largest short position increases include Ganfeng Lithium, which rose from 7.67% to 9.70%, and Sanhua Intelligent Control, which increased from 5.76% to 7.39% [2] - The companies with the largest short position decreases include Kanglong Chemical, which fell from 5.35% to 3.64%, and Aneng Logistics, which dropped from 2.68% to 1.00% [3][4]
智通AH统计|2月6日
智通财经网· 2026-02-06 08:19
Core Viewpoint - The report highlights the premium rates of AH shares, with Northeast Electric, Zhejiang Shibao, and Sinopec Oilfield Services leading in premium rates, while CATL, China Merchants Bank, and WuXi AppTec are at the bottom of the list [1][2][3]. Premium Rate Rankings - The top three AH shares by premium rate are: - Northeast Electric (00042) with a premium rate of 831.03% - Zhejiang Shibao (01057) with a premium rate of 353.97% - Sinopec Oilfield Services (01033) with a premium rate of 302.25% [2] - The bottom three AH shares by premium rate are: - CATL (03750) with a premium rate of -11.84% - China Merchants Bank (03968) with a premium rate of -3.56% - WuXi AppTec (02359) with a premium rate of 1.72% [3] Deviation Value Rankings - The top three shares by deviation value are: - Dazhu CNC (03200) with a deviation value of 60.25% - Muyuan Foods (02714) with a deviation value of 37.19% - Beijing Jingcheng Machinery Electric (00187) with a deviation value of 27.09% [1][4] - The bottom three shares by deviation value are: - Zhejiang Shibao (01057) with a deviation value of -39.99% - Junda Co., Ltd. (02865) with a deviation value of -35.13% - Yangtze Optical Fibre and Cable (06869) with a deviation value of -23.61% [1][5]
药明康德涨0.74%,成交额34.38亿元,今日主力净流入8223.71万
Xin Lang Cai Jing· 2026-02-06 07:56
来源:新浪证券-红岸工作室 2月6日,药明康德涨0.74%,成交额34.38亿元,换手率1.42%,总市值2919.01亿元。 异动分析 CRO概念+创新药+人民币贬值受益 1、公司是国际领先的开放式能力与技术平台,为全球生物医药行业提供全方位、一体化的新药研发和生 产服务。 2、国内医药外包行业龙头,是国内最早开始从事医药研发生产外包的CRO和CMO一体化公司,高层管理 团队共拥有超过200项的已授权和申请中的专利成果;其主营业务为小分子化学药的发现、研发及生产的 全方位、一体化平台服务,以全产业链平台的形式面向全球制药企业提供各类新药的研发、生产及配套 服务;公司还在境外提供医疗器械检测及境外精准医疗研发生产服务。 3、根据2024年年报,公司海外营收占比为78.67%,受益于人民币贬值。 (免责声明:分析内容来源于互联网,不构成投资建议,请投资者根据不同行情独立判断) 资金分析 区间今日近3日近5日近10日近20日主力净流入8223.71万4.43亿1.70亿-2076.06万-14.47亿 主力持仓 主力没有控盘,筹码分布非常分散,主力成交额7.54亿,占总成交额的5.73%。 技术面:筹码平均交易成 ...